{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T12:11:09Z","timestamp":1779883869861,"version":"3.53.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,16]],"date-time":"2016-11-16T00:00:00Z","timestamp":1479254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,11,16]],"date-time":"2016-11-16T00:00:00Z","timestamp":1479254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cancer cells of epithelial and mesenchymal phenotypes exhibit different sensitivities to apoptosis stimuli, but the mechanisms underlying this phenomenon remain partly understood. We constructed a novel recombinant adenovirus expressing Ad12 E1A (Ad-E1A12) that can strongly induce apoptosis. Ad-E1A12 infection of epithelial cancer cells displayed dramatic detachment and apoptosis, whereas cancer cells of mesenchymal phenotypes with metastatic propensity were markedly more resistant to this virus. Notably, forced detachment of epithelial cells did not further sensitize them to Ad-E1A12-induced apoptosis, suggesting that cell detachment is a consequence rather than the cause of Ad-E1A12-induced apoptosis. Ad-E1A12 increased phosphorylation of AKT1 and ribosomal protein S6 through independent mechanisms in different cell types. Ad-E1A12\u2013induced AKT1 phosphorylation was PI3K-dependent in epithelial cancer cells, and mTOR-dependent in mesenchymal cancer cells. Epithelial cancer cells upon Ad-E1A12-induced detachment could not sustain AKT activation due to AKT1 degradation, but AKT1 activation was maintained in mesenchymal cancer cells. Expression of epithelial cell-restricted miR-200 family in mesenchymal cells limited mTOR signaling and sensitized them to Ad-E1A12-induced cell killing. Thus, epithelial cancer cells rely on the canonical PI3K-AKT signaling pathway for survival, while mesenchymal cancer cells deploy the PI3K-independent mTORC2-AKT axis in response to strong death stimuli.<\/jats:p>","DOI":"10.1038\/srep37213","type":"journal-article","created":{"date-parts":[[2016,11,16]],"date-time":"2016-11-16T11:32:09Z","timestamp":1479295929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Intrinsic cellular signaling mechanisms determine the sensitivity of cancer cells to virus-induced apoptosis"],"prefix":"10.1038","volume":"6","author":[{"given":"Yunfei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guimei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa Y.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiqing","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,16]]},"reference":[{"key":"BFsrep37213_CR1","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1083\/jcb.124.4.619","volume":"124","author":"SM Frisch","year":"1994","unstructured":"Frisch, S. M. & Francis, H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 124, 619\u2013626 (1994).","journal-title":"J Cell Biol"},{"key":"BFsrep37213_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1074\/jbc.M110.169821","volume":"286","author":"AR Grassian","year":"2011","unstructured":"Grassian, A. R., Schafer, Z. T. & Brugge, J. S. ErbB2 stabilizes epidermal growth factor receptor (EGFR) expression via Erk and Sprouty2 in extracellular matrix-detached cells. J Biol Chem 286, 79\u201390, doi: 10.1074\/jbc.M110.169821 (2011).","journal-title":"J Biol Chem"},{"key":"BFsrep37213_CR3","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/ncb1026","volume":"5","author":"MJ Reginato","year":"2003","unstructured":"Reginato, M. J. et al. Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis. Nat Cell Biol 5, 733\u2013740, doi: 10.1038\/ncb1026 (2003).","journal-title":"Nat Cell Biol"},{"key":"BFsrep37213_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nature08268","volume":"461","author":"ZT Schafer","year":"2009","unstructured":"Schafer, Z. T. et al. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature 461, 109\u2013113, doi: 10.1038\/nature08268 (2009).","journal-title":"Nature"},{"key":"BFsrep37213_CR5","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1016\/j.bbamcr.2013.06.026","volume":"1833","author":"P Paoli","year":"2013","unstructured":"Paoli, P., Giannoni, E. & Chiarugi, P. Anoikis molecular pathways and its role in cancer progression. Biochim Biophys Acta 1833, 3481\u20133498, doi: 10.1016\/j.bbamcr.2013.06.026 (2013).","journal-title":"Biochim Biophys Acta"},{"key":"BFsrep37213_CR6","doi-asserted-by":"publisher","first-page":"306879","DOI":"10.1155\/2012\/306879","volume":"2012","author":"YN Kim","year":"2012","unstructured":"Kim, Y. N., Koo, K. H., Sung, J. Y., Yun, U. J. & Kim, H. Anoikis resistance: an essential prerequisite for tumor metastasis. Int J Cell Biol 2012, 306879, doi: 10.1155\/2012\/306879 (2012).","journal-title":"Int J Cell Biol"},{"key":"BFsrep37213_CR7","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.1038\/sj.onc.1203805","volume":"19","author":"M Rytomaa","year":"2000","unstructured":"Rytomaa, M., Lehmann, K. & Downward, J. Matrix detachment induces caspase-dependent cytochrome c release from mitochondria: inhibition by PKB\/Akt but not Raf signalling. Oncogene 19, 4461\u20134468, doi: 10.1038\/sj.onc.1203805 (2000).","journal-title":"Oncogene"},{"key":"BFsrep37213_CR8","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1093\/emboj\/16.10.2783","volume":"16","author":"A Khwaja","year":"1997","unstructured":"Khwaja, A., Rodriguez-Viciana, P., Wennstrom, S., Warne, P. H. & Downward, J. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B\/Akt cellular survival pathway. EMBO J 16, 2783\u20132793, doi: 10.1093\/emboj\/16.10.2783 (1997).","journal-title":"EMBO J"},{"key":"BFsrep37213_CR9","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1038\/nm.3336","volume":"19","author":"WL Tam","year":"2013","unstructured":"Tam, W. L. & Weinberg, R. A. The epigenetics of epithelial-mesenchymal plasticity in cancer. Nat Med 19, 1438\u20131449, doi: 10.1038\/nm.3336 (2013).","journal-title":"Nat Med"},{"key":"BFsrep37213_CR10","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/ncb1722","volume":"10","author":"PA Gregory","year":"2008","unstructured":"Gregory, P. A. et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10, 593\u2013601, doi: 10.1038\/ncb1722 (2008).","journal-title":"Nat Cell Biol"},{"key":"BFsrep37213_CR11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2147\/CMAR.S35171","volume":"5","author":"CJ Creighton","year":"2013","unstructured":"Creighton, C. J., Gibbons, D. L. & Kurie, J. M. The role of epithelial-mesenchymal transition programming in invasion and metastasis: a clinical perspective. Cancer Manag Res 5, 187\u2013195, doi: 10.2147\/CMAR.S35171 (2013).","journal-title":"Cancer Manag Res"},{"key":"BFsrep37213_CR12","doi-asserted-by":"publisher","first-page":"R45","DOI":"10.1186\/bcr2867","volume":"13","author":"EN Howe","year":"2011","unstructured":"Howe, E. N., Cochrane, D. R. & Richer, J. K. Targets of miR-200c mediate suppression of cell motility and anoikis resistance. Breast Cancer Res 13, R45, doi: 10.1186\/bcr2867 (2011).","journal-title":"Breast Cancer Res"},{"key":"BFsrep37213_CR13","doi-asserted-by":"publisher","first-page":"e49987","DOI":"10.1371\/journal.pone.0049987","volume":"7","author":"EN Howe","year":"2012","unstructured":"Howe, E. N., Cochrane, D. R., Cittelly, D. M. & Richer, J. K. miR-200c targets a NF-kappaB up-regulated TrkB\/NTF3 autocrine signaling loop to enhance anoikis sensitivity in triple negative breast cancer. PLoS ONE 7, e49987, doi: 10.1371\/journal.pone.0049987 (2012).","journal-title":"PLoS ONE"},{"key":"BFsrep37213_CR14","doi-asserted-by":"publisher","first-page":"R33","DOI":"10.1186\/bcr3415","volume":"15","author":"M Riaz","year":"2013","unstructured":"Riaz, M. et al. miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs. Breast Cancer Res 15, R33, doi: 10.1186\/bcr3415 (2013).","journal-title":"Breast Cancer Res"},{"key":"BFsrep37213_CR15","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.hoc.2013.05.003","volume":"27","author":"CK Anders","year":"2013","unstructured":"Anders, C. K., Zagar, T. M. & Carey, L. A. The management of early-stage and metastatic triple-negative breast cancer: a review. Hematol Oncol Clin North Am 27, 737\u2013749, doi: 10.1016\/j.hoc.2013.05.003 (2013).","journal-title":"Hematol Oncol Clin North Am"},{"key":"BFsrep37213_CR16","doi-asserted-by":"crossref","unstructured":"TCGA. Comprehensive molecular portraits of human breast tumours. Nature 490, 61\u201370, doi: 10.1038\/nature11412 (2012).","DOI":"10.1038\/nature11412"},{"key":"BFsrep37213_CR17","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1083\/jcb.127.4.1085","volume":"127","author":"SM Frisch","year":"1994","unstructured":"Frisch, S. M. E1a induces the expression of epithelial characteristics. J Cell Biol 127, 1085\u20131096 (1994).","journal-title":"J Cell Biol"},{"key":"BFsrep37213_CR18","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1038\/sj.onc.1203721","volume":"19","author":"ML Grooteclaes","year":"2000","unstructured":"Grooteclaes, M. L. & Frisch, S. M. Evidence for a function of CtBP in epithelial gene regulation and anoikis. Oncogene 19, 3823\u20133828, doi: 10.1038\/sj.onc.1203721 (2000).","journal-title":"Oncogene"},{"key":"BFsrep37213_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0042-6822(83)90369-0","volume":"127","author":"R Bernards","year":"1983","unstructured":"Bernards, R., Schrier, P. I., Bos, J. L. & Van der Eb, A. J. Role of adenovirus types 5 and 12 early region 1b tumor antigens in oncogenic transformation. Virology 127, 45\u201353 (1983).","journal-title":"Virology"},{"key":"BFsrep37213_CR20","doi-asserted-by":"publisher","first-page":"5540","DOI":"10.1128\/MCB.20.15.5540-5553.2000","volume":"20","author":"Y Liu","year":"2000","unstructured":"Liu, Y., Colosimo, A. L., Yang, X. J. & Liao, D. Adenovirus E1B 55-kilodalton oncoprotein inhibits p53 acetylation by PCAF. Mol Cell Biol 20, 5540\u20135553 (2000).","journal-title":"Mol Cell Biol"},{"key":"BFsrep37213_CR21","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nrm827","volume":"3","author":"SM Frisch","year":"2002","unstructured":"Frisch, S. M. & Mymryk, J. S. Adenovirus-5 E1A: paradox and paradigm. Nat Rev Mol Cell Biol 3, 441\u2013452 (2002).","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFsrep37213_CR22","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1006\/viro.1998.9583","volume":"255","author":"KS Lipinski","year":"1999","unstructured":"Lipinski, K. S. et al. Differences in the interactions of oncogenic adenovirus 12 early region 1A and nononcogenic adenovirus 2 early region 1A with the cellular coactivators p300 and CBP. Virology 255, 94\u2013105, doi: 10.1006\/viro.1998.9583 (1999).","journal-title":"Virology"},{"key":"BFsrep37213_CR23","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1128\/JVI.00104-08","volume":"82","author":"P Pelka","year":"2008","unstructured":"Pelka, P., Ablack, J. N., Fonseca, G. J., Yousef, A. F. & Mymryk, J. S. Intrinsic structural disorder in adenovirus E1A: a viral molecular hub linking multiple diverse processes. J Virol 82, 7252\u20137263 (2008).","journal-title":"J Virol"},{"key":"BFsrep37213_CR24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1101\/gad.173435.111","volume":"26","author":"B Zhao","year":"2012","unstructured":"Zhao, B. et al. Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis. Genes Dev 26, 54\u201368, doi: 10.1101\/gad.173435.111 (2012).","journal-title":"Genes Dev"},{"key":"BFsrep37213_CR25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nrc3876","volume":"15","author":"T Moroishi","year":"2015","unstructured":"Moroishi, T., Hansen, C. G. & Guan, K. L. The emerging roles of YAP and TAZ in cancer. Nat Rev Cancer 15, 73\u201379, doi: 10.1038\/nrc3876 (2015).","journal-title":"Nat Rev Cancer"},{"key":"BFsrep37213_CR26","doi-asserted-by":"publisher","first-page":"30054","DOI":"10.1074\/jbc.M113.481283","volume":"288","author":"JW Lee","year":"2013","unstructured":"Lee, J. W. & Kim, J. H. Activation of the Leukotriene B4 Receptor 2-Reactive Oxygen Species (BLT2-ROS) Cascade following Detachment Confers Anoikis Resistance in Prostate Cancer Cells. J Biol Chem 288, 30054\u201330063, doi: 10.1074\/jbc.M113.481283 (2013).","journal-title":"J Biol Chem"},{"key":"BFsrep37213_CR27","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1038\/onc.2011.465","volume":"31","author":"EC Piccione","year":"2012","unstructured":"Piccione, E. C. et al. A novel epidermal growth factor receptor variant lacking multiple domains directly activates transcription and is overexpressed in tumors. Oncogene 31, 2953\u20132967, doi: 10.1038\/onc.2011.465 (2012).","journal-title":"Oncogene"},{"key":"BFsrep37213_CR28","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/sj.onc.1206151","volume":"22","author":"KK Frese","year":"2003","unstructured":"Frese, K. K. et al. Selective PDZ protein-dependent stimulation of phosphatidylinositol 3-kinase by the adenovirus E4-ORF1 oncoprotein. Oncogene 22, 710\u2013721, doi: 10.1038\/sj.onc.1206151 (2003).","journal-title":"Oncogene"},{"key":"BFsrep37213_CR29","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1128\/JVI.01972-08","volume":"83","author":"MA Thomas","year":"2009","unstructured":"Thomas, M. A., Broughton, R. S., Goodrum, F. D. & Ornelles, D. A. E4orf1 limits the oncolytic potential of the E1B-55K deletion mutant adenovirus. J Virol 83, 2406\u20132416, doi: 10.1128\/JVI.01972-08 (2009).","journal-title":"J Virol"},{"key":"BFsrep37213_CR30","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/sj.emboj.7600597","volume":"24","author":"C O\u2032Shea","year":"2005","unstructured":"O\u2032Shea, C. et al. Adenoviral proteins mimic nutrient\/growth signals to activate the mTOR pathway for viral replication. EMBO J 24, 1211\u20131221, doi: 10.1038\/sj.emboj.7600597 (2005).","journal-title":"EMBO J"},{"key":"BFsrep37213_CR31","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1101\/gad.1640608","volume":"22","author":"SM Park","year":"2008","unstructured":"Park, S. M., Gaur, A. B., Lengyel, E. & Peter, M. E. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22, 894\u2013907, doi: 10.1101\/gad.1640608 (2008).","journal-title":"Genes Dev"},{"key":"BFsrep37213_CR32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10911-012-9244-6","volume":"17","author":"EN Howe","year":"2012","unstructured":"Howe, E. N., Cochrane, D. R. & Richer, J. K. The miR-200 and miR-221\/222 microRNA families: opposing effects on epithelial identity. J Mammary Gland Biol Neoplasia 17, 65\u201377, doi: 10.1007\/s10911-012-9244-6 (2012).","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"BFsrep37213_CR33","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1002\/ijc.28151","volume":"133","author":"Y Yu","year":"2013","unstructured":"Yu, Y. et al. Kindlin 2 promotes breast cancer invasion via epigenetic silencing of the microRNA200 gene family. Int J Cancer 133, 1368\u20131379, doi: 10.1002\/ijc.28151 (2013).","journal-title":"Int J Cancer"},{"key":"BFsrep37213_CR34","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1073\/pnas.1018854108","volume":"109","author":"LM Heiser","year":"2012","unstructured":"Heiser, L. M. et al. Subtype and pathway specific responses to anticancer compounds in breast cancer. Proc Natl Acad Sci USA 109, 2724\u20132729, doi: 10.1073\/pnas.1018854108 (2012).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep37213_CR35","doi-asserted-by":"publisher","first-page":"ra84","DOI":"10.1126\/scisignal.2004379","volume":"6","author":"M Niepel","year":"2013","unstructured":"Niepel, M. et al. Profiles of Basal and stimulated receptor signaling networks predict drug response in breast cancer lines. Sci Signal 6, ra84, doi: 10.1126\/scisignal.2004379 (2013).","journal-title":"Sci Signal"},{"key":"BFsrep37213_CR36","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1038\/onc.2011.22","volume":"30","author":"EK Kim","year":"2011","unstructured":"Kim, E. K. et al. Selective activation of Akt1 by mammalian target of rapamycin complex 2 regulates cancer cell migration, invasion, and metastasis. Oncogene 30, 2954\u20132963, doi: 10.1038\/onc.2011.22 (2011).","journal-title":"Oncogene"},{"key":"BFsrep37213_CR37","doi-asserted-by":"publisher","first-page":"9360","DOI":"10.1158\/0008-5472.CAN-10-0207","volume":"70","author":"F Zhang","year":"2010","unstructured":"Zhang, F. et al. mTOR complex component Rictor interacts with PKCzeta and regulates cancer cell metastasis. Cancer Res 70, 9360\u20139370, doi: 10.1158\/0008-5472.CAN-10-0207 (2010).","journal-title":"Cancer Res"},{"key":"BFsrep37213_CR38","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s10549-012-2036-2","volume":"134","author":"H Li","year":"2012","unstructured":"Li, H. et al. Targeting of mTORC2 prevents cell migration and promotes apoptosis in breast cancer. Breast Cancer Res Treat 134, 1057\u20131066, doi: 10.1007\/s10549-012-2036-2 (2012).","journal-title":"Breast Cancer Res Treat"},{"key":"BFsrep37213_CR39","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1158\/0008-5472.CAN-10-4058","volume":"71","author":"P Gulhati","year":"2011","unstructured":"Gulhati, P. et al. mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways. Cancer Res 71, 3246\u20133256, doi: 10.1158\/0008-5472.CAN-10-4058 (2011).","journal-title":"Cancer Res"},{"key":"BFsrep37213_CR40","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1158\/2159-8290.CD-11-0124","volume":"1","author":"K Tanaka","year":"2011","unstructured":"Tanaka, K. et al. Oncogenic EGFR signaling activates an mTORC2-NF-kappaB pathway that promotes chemotherapy resistance. Cancer Discov 1, 524\u2013538, doi: 10.1158\/2159-8290.CD-11-0124 (2011).","journal-title":"Cancer Discov"},{"key":"BFsrep37213_CR41","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1158\/0008-5472.CAN-12-3710","volume":"73","author":"L Zhao","year":"2013","unstructured":"Zhao, L., Yue, P., Khuri, F. R. & Sun, S. Y. mTOR complex 2 is involved in regulation of Cbl-dependent c-FLIP degradation and sensitivity of TRAIL-induced apoptosis. Cancer Res 73, 1946\u20131957, doi: 10.1158\/0008-5472.CAN-12-3710 (2013).","journal-title":"Cancer Res"},{"key":"BFsrep37213_CR42","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1530\/ERC-11-0278","volume":"19","author":"SI Park","year":"2012","unstructured":"Park, S. I. & McCauley, L. K. Nuclear localization of parathyroid hormone-related peptide confers resistance to anoikis in prostate cancer cells. Endocr Relat Cancer 19, 243\u2013254, doi: 10.1530\/ERC-11-0278 (2012).","journal-title":"Endocr Relat Cancer"},{"key":"BFsrep37213_CR43","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ejphar.2013.05.046","volume":"714","author":"H Wang","year":"2013","unstructured":"Wang, H. et al. Stabilization of Snail through AKT\/GSK-3beta signaling pathway is required for TNF-alpha-induced epithelial-mesenchymal transition in prostate cancer PC3 cells. Eur J Pharmacol 714, 48\u201355, doi: 10.1016\/j.ejphar.2013.05.046 (2013).","journal-title":"Eur J Pharmacol"},{"key":"BFsrep37213_CR44","doi-asserted-by":"publisher","first-page":"27019","DOI":"10.1074\/jbc.M113.498055","volume":"288","author":"CH Chen","year":"2013","unstructured":"Chen, C. H. et al. Autoregulation of the Mechanistic Target of Rapamycin (mTOR) Complex 2 Integrity Is Controlled by an ATP-dependent Mechanism. J Biol Chem 288, 27019\u201327030, doi: 10.1074\/jbc.M113.498055 (2013).","journal-title":"J Biol Chem"},{"key":"BFsrep37213_CR45","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.2337\/db09-1061","volume":"59","author":"A Kumar","year":"2010","unstructured":"Kumar, A. et al. Fat cell-specific ablation of rictor in mice impairs insulin-regulated fat cell and whole-body glucose and lipid metabolism. Diabetes 59, 1397\u20131406, doi: 10.2337\/db09-1061 (2010).","journal-title":"Diabetes"},{"key":"BFsrep37213_CR46","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.cmet.2013.08.002","volume":"18","author":"DW Lamming","year":"2013","unstructured":"Lamming, D. W. & Sabatini, D. M. A Central Role for mTOR in Lipid Homeostasis. Cell Metab 18, 465\u2013469, doi: 10.1016\/j.cmet.2013.08.002 (2013).","journal-title":"Cell Metab"},{"key":"BFsrep37213_CR47","doi-asserted-by":"publisher","first-page":"29579","DOI":"10.1074\/jbc.M112.386854","volume":"287","author":"M Yuan","year":"2012","unstructured":"Yuan, M., Pino, E., Wu, L., Kacergis, M. & Soukas, A. A. Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2. J Biol Chem 287, 29579\u201329588, doi: 10.1074\/jbc.M112.386854 (2012).","journal-title":"J Biol Chem"},{"key":"BFsrep37213_CR48","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.cmet.2012.03.015","volume":"15","author":"A Hagiwara","year":"2012","unstructured":"Hagiwara, A. et al. Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c. Cell Metab 15, 725\u2013738, doi: 10.1016\/j.cmet.2012.03.015 (2012).","journal-title":"Cell Metab"},{"key":"BFsrep37213_CR49","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.cmet.2013.09.013","volume":"18","author":"K Masui","year":"2013","unstructured":"Masui, K. et al. mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc. Cell Metab 18, 726\u2013739, doi: 10.1016\/j.cmet.2013.09.013 (2013).","journal-title":"Cell Metab"},{"key":"BFsrep37213_CR50","doi-asserted-by":"crossref","unstructured":"TCGA. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609\u2013615, doi: 10.1038\/nature10166 (2011).","DOI":"10.1038\/nature10166"},{"key":"BFsrep37213_CR51","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/ncb2860","volume":"15","author":"P Liu","year":"2013","unstructured":"Liu, P. et al. Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis. Nat Cell Biol 15, 1340\u20131350, doi: 10.1038\/ncb2860 (2013).","journal-title":"Nat Cell Biol"},{"key":"BFsrep37213_CR52","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ccr.2008.12.017","volume":"15","author":"DA Guertin","year":"2009","unstructured":"Guertin, D. A. et al. mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice. Cancer Cell 15, 148\u2013159, doi: 10.1016\/j.ccr.2008.12.017 (2009).","journal-title":"Cancer Cell"},{"key":"BFsrep37213_CR53","doi-asserted-by":"publisher","first-page":"7673","DOI":"10.1038\/sj.onc.1209040","volume":"24","author":"AJ Berk","year":"2005","unstructured":"Berk, A. J. Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus. Oncogene 24, 7673\u20137685 (2005).","journal-title":"Oncogene"},{"key":"BFsrep37213_CR54","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1158\/0008-5472.CAN-11-2089","volume":"73","author":"SE Pool","year":"2013","unstructured":"Pool, S. E. et al. mTOR inhibitor RAD001 promotes metastasis in a rat model of pancreatic neuroendocrine cancer. Cancer Res 73, 12\u201318, doi: 10.1158\/0008-5472.CAN-11-2089 (2013).","journal-title":"Cancer Res"},{"key":"BFsrep37213_CR55","doi-asserted-by":"publisher","first-page":"7976","DOI":"10.1128\/JVI.00492-11","volume":"85","author":"Q Li","year":"2011","unstructured":"Li, Q. et al. Inhibition of p53 by Adenovirus Type 12 E1B-55K Deregulates Cell Cycle Control and Sensitizes Tumor Cells to Genotoxic Agents. J Virol 85, 7976\u20137988, doi: 10.1128\/JVI.00492-11 (2011).","journal-title":"J Virol"},{"key":"BFsrep37213_CR56","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1158\/1535-7163.MCT-12-0930","volume":"12","author":"H Yang","year":"2013","unstructured":"Yang, H. et al. Small-Molecule Inhibitors of Acetyltransferase p300 Identified by High-Throughput Screening Are Potent Anticancer Agents. Mol Cancer Ther 12, 610\u2013620, doi: 10.1158\/1535-7163.MCT-12-0930 (2013).","journal-title":"Mol Cancer Ther"},{"key":"BFsrep37213_CR57","doi-asserted-by":"publisher","first-page":"582","DOI":"10.4161\/cc.11.3.19052","volume":"11","author":"H Yang","year":"2012","unstructured":"Yang, H., Zheng, Z., Zhao, L. Y., Li, Q. & Liao, D. Downregulation of Mdm2 and Mdm4 enhances viral gene expression during adenovirus infection. Cell Cycle 11, 582\u2013593, doi: 10.4161\/cc.11.3.19052 (2012).","journal-title":"Cell Cycle"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep37213.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep37213","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep37213.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T02:29:57Z","timestamp":1672885797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep37213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,16]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,23]]}},"alternative-id":["BFsrep37213"],"URL":"https:\/\/doi.org\/10.1038\/srep37213","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,16]]},"assertion":[{"value":"12 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37213"}}